By Susan Brinkmann, OCDS
Staff Journalist
The U.S. Food and Drug Administration (FDA) has approved the world’s first human clinical trial of a therapy involving embryonic stem cells, a move that has been condemned by the Vatican as “unacceptable.”
By Susan Brinkmann, OCDS
Staff Journalist
The U.S. Food and Drug Administration (FDA) has approved the world’s first human clinical trial of a therapy involving embryonic stem cells, a move that has been condemned by the Vatican as “unacceptable.”
